home / stock / lly / lly articles

LLY Articles, Eli Lilly and Company - From 02/09/24

Stock Information
Company Name: Eli Lilly and Company
Stock Symbol: LLY
Market: NYSE
Website: lilly.com
Menu
LLY LLY Quote LLY Short LLY News LLY Articles LLY Message Board
Get LLY Alerts

News, Short Squeeze, Breakout and More Instantly...
Jim Cramer Says Investors Should Look Beyond Apple, Meta And Other Magnificent 7 Stocks: 'You Might Be Missing Out On Some Huge Gains' | Benzinga

Jim Cramer, the host of CNBC’s “Mad Money,” has suggested that investors should look beyond the Magnificent Seven tech stocks for...
Why Foghorn Therapeutics (FHTX) Stock Is Exploding Higher | Benzinga

Foghorn Therapeutics Inc. (NASDAQ:FHTX) shares are trading higher by 44.8% to $4.52 during Thursday’s session after the company announced tha...

What's Going On Eli Lilly Stock Thursday? | Benzinga

Since Monday, Eli Lilly And Co (NYSE:LLY) shares have gained 8%, closing at $724.85 on Wednesday, sending the market capitalization to a ...

Apple, Chipotle And Eli Lilly Stocks Baffle Jim Cramer With Unusual Moves: 'Authentic Stupidity Is A Perfectly Plausible Explanation' | Benzinga

Jim Cramer, the host of CNBC’s “Mad Money,” expressed skepticism regarding the recent market movements of Apple Inc (NASDAQ:AAPL)...
Analysts Boost Eli Lilly's Forecast With High Hopes On Mounjaro, Zepbound Performance | Benzinga

Tuesday, Eli Lilly And Co (NYSE:LLY) reported fourth-quarter of 2023 revenue of $9.35 billion, up 28% Y/Y, beating the consensus of $8.93...

Dow Jumps Over 100 Points; Eli Lilly Posts Upbeat Earnings | Benzinga

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Tuesday. Following the market opening Tuesday, the...

Eli Lilly Soars On Diabetes And Obesity Drug Boom, Projects 20% Revenue Increase In 2024 | Benzinga

In a recent announcement, Eli Lilly and Co (NYSE:LLY) has projected a significant revenue increase for 2024, driven by the demand for its diabetes ...
Investors Cheer Highly Awaited Eli Lilly Earnings, Q4 Performance Surpass Expectations Thanks To Strong Zepbound Launch, Surging Weight loss Drug Sales | Benzinga

Tuesday, Eli Lilly And Co (NYSE:LLY) reported fourth-quarter of 2023 revenue of $9.35 billion, up 28% Y/Y, beating the consensus of $8.93...

Investors Cheer Eli Lilly Earnings, Q4 Performance Surpasses Expectations Thanks To Strong Zepbound Launch, Surging Weight Loss Drug Sales | Benzinga

Tuesday, Eli Lilly And Co (NYSE:LLY) reported fourth-quarter of 2023 revenue of $9.35 billion, up 28% Y/Y, beating the consensus of $8.93...

US Stocks Brace For Another Day In The Red As Rally Loses Steam: Analyst Sees Market Pullback On This Indicator | Benzinga

U.S. stocks are poised for another day of weakness, although some positive tech earnings may provide a modest lift to the sector. The market appe...
Previous 10 Next 10